Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 04-2014 | 01-2014 | 10-2013 | 07-2013 | 04-2013 | |
| Operating Expenses | 99 | 86 | 82 | 99 | 118 |
| Operating Income | -99 | -86 | -82 | -99 | -118 |
| Other Income | -434 | 4 | -72 | -3 | 8 |
| Pre-tax Income | -533 | -82 | -153 | -102 | -110 |
| Net Income Continuous | -533 | -82 | -153 | -102 | -110 |
| Net Income | $-533 | $-82 | $-153 | $-102 | $-110 |
| EPS Basic Total Ops | -2.74 | 0.00 | 0.00 | N/A | 0.00 |
| EPS Basic Continuous Ops | -2.81 | -0.43 | -0.81 | 1.07 | -0.58 |
| EPS Diluted Total Ops | -2.74 | 0.00 | 0.00 | N/A | 0.00 |
| EPS Diluted Continuous Ops | -2.81 | -0.43 | -0.81 | 1.07 | -0.58 |
| EBITDA(a) | $-99 | $-86 | $-81 | $-99 | $-118 |